PMC:7546122 / 3423-3705
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T18 | 54-62 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T19 | 237-261 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T20 | 263-271 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T30 | 214-215 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T5 | 171-190 | Phenotype | denotes | immune deficiencies | http://purl.obolibrary.org/obo/HP_0002721 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T20 | 0-282 | Sentence | denotes | The question is of significant clinical relevance, as SARS-CoV-2 cross-neutralizing antibodies in IVIGs, if they were present, might afford some protection to people with immune deficiencies and may even represent a treatment option for coronavirus disease 2019 (COVID-19) patients. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 83 | 54-64 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 84 | 159-165 | Species | denotes | people | Tax:9606 |
| 85 | 273-281 | Species | denotes | patients | Tax:9606 |
| 86 | 237-261 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
| 87 | 263-271 | Disease | denotes | COVID-19 | MESH:C000657245 |